OCCURRENCE OF DYSLIPIDEMIA IN NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS PATIENTS
Main Article Content
Keywords
Diabetes, Glucose, Cholesterol, Cardiovascular
Abstract
According to past research, the incidence of diabetes has increased by three times in both urban and rural regions, and in the near future, Pakistan will have a high number of diabetes patients. Due to alterations in lipid profiles, type 2 DM patients are more likely to develop vascular problems. Increased blood levels of triglycerides (TGs), total cholesterol (TC), or both, or decreased levels of elevated lipoprotein cholesterol are signs of diabetic dyslipidemia, which is more atherogenic (HDL-C). The risk of cardiovascular illnesses may be reduced by managing dyslipidemia.
OBJECTIVE: The aim of this research was to ascertain the occurrence of dyslipidemia in type-II diabetes mellitus patients who had just received their diagnosis.
METHODS: the research was carried out at the Fatima Memorial Hospital Lahore. In the research, 100 people with type 2 diabetes who had just received a diagnosis were enrolled as cases, while 100 healthy people were included as controls. Both the control and cases groups' participants provided blood samples, which were then tested for fasting and post-meal plasma glucose, HDL-C, LDL-C, TG, TC, and HbA1c.
RESULTS: Only 52% of controls were found to have dyslipidemia, compared to 84% of cases, and it was statistically significant that both the groups are different with p-value = 0.05. In comparison to the controls, the cases had higher mean values for fasting and postprandial plasma glucose, HbA1c, LDL-C, TG, TC, and HbA1c (p0.05).
CONCLUSIONS: This study demonstrated a favorable relationship between serum total cholesterol and glycemic parameters, LDL cholesterol, and triglycerides, and exhibited that dyslipidemia is frequent in recently diagnosed T2DM patients (p0.05). Since dyslipidemia is an established risk factor for cardiovascular illnesses, our research emphasizes the need and significance of taking action to reduce it in diabetes individuals.
References
2. Rao, P. H., & Reddy, G. M. M. A cross-sectional study to determine the lipid profile derangement in newly diagnosed type-2 diabetic patients. Age, 20(30), 3.
3. El Alami, H., Haddou, I., Benaadi, G., Lkhider, M., El Habchi, D., Wakrim, L., ... & Hamdi, S. (2022). Prevalence and risk factors of chronic complications among patients with type 2 diabetes mellitus in Morocco: a cross-sectional study. The Pan African Medical Journal, 41.
4. Zhu, D., Li, X., Ma, J., Zeng, J. E., Gan, S., Dong, X., ... & Chen, L. (2022). Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial. Nature Medicine, 28(5), 965-973.
5. GRADE Study Research Group. (2022). Glycemia reduction in type 2 diabetes—microvascular and cardiovascular outcomes. New England Journal of Medicine, 387(12), 1075-1088.
6. Wang, C., Xie, Z., Huang, X., Wang, Z., ShangGuan, H., & Wang, S. (2022). Prevalence of cardiovascular disease risk factors in Chinese patients with type 2 diabetes mellitus, 2013–2018. Current Medical Research and Opinion, 38(3), 345-354.
7. Wu, T. H., Lee, I. T., Ho, L. T., Sheu, W. H. H., & Hwu, C. M. (2022). Combined lipid goal attainment in patients with type 2 diabetes and dyslipidemia: a head-to-head comparative trial of statins. Journal of the Chinese Medical Association, 85(8), 831-838.
8. Mangione, C. M., Barry, M. J., Nicholson, W. K., Cabana, M., Chelmow, D., Coker, T. R., ... & US Preventive Services Task Force. (2022). Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. JAMA, 328(10), 963-967.
9. Dündar, İ., & Akıncı, A. (2022). Prevalence of type 2 diabetes mellitus, metabolic syndrome, and related morbidities in overweight and obese children. Journal of Pediatric Endocrinology and Metabolism, 35(4), 435-441.
10. Tang, X., Yan, X., Zhou, H., Huang, G., Niu, X., Jiang, H., ... & Zhou, Z. (2022). Associations of insulin resistance and beta-cell function with abnormal lipid profile in newly diagnosed diabetes. Chinese Medical Journal.
11. Qi, L., Kang, N., Chen, X., Li, Z., Deng, C., & Chen, S. (2022). Predictive Value of Plasma Atherogenic Index for Microalbuminuria in Newly Diagnosed Patients with Type 2 Diabetes Mellitus. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 15, 1245.
12. Vijayabaskaran, S., Damodaran, V., & Nagarajan, S. (2022). Association between Lipid Levels and Short-Term Heart Rate Variability (HRV) In Type 2 Diabetes. Egyptian Academic Journal of Biological Sciences. C, Physiology and Molecular Biology, 14(1), 21-30.
13. Memon, A., Siddiqui, S. S., Ata, M. A., Shaikh, K. R., Soomro, U. A., & Shaikh, S. (2022). Silymarin improves glycemic control through reduction of insulin resistance in newly diagnosed patients of type 2 diabetes mellitus. The Professional Medical Journal, 29(03), 362-366.
14. Jha, U. C., Kumar, B., & Das, N. L. An Observational Descriptive Assessment of Lipid Profile of Diabetic Patients Visiting Tertiary Care Facility.
15. Kumar, N., & Lohani, K. K. A Cross-Sectional Observational Study to Evaluate the Lipid Profiles Mainly Triglycerides in Diabetic Patients from Bihar Region.
16. Raja, S. A., Chong, V. H., Rahman, N. A., Shakir, L. M., & Knights, J. (2022). Prevalence and Associated Factors of Diabetic Retinopathy among Type 2 Diabetes Mellitus Patients in Brunei Darussalam: A Cross-sectional Study. Korean Journal of Ophthalmology: KJO, 36(1), 26.
17. Leiter, L. A., Banach, M., Catapano, A. L., Duell, P. B., Gotto Jr, A. M., Laufs, U., ... & Bays, H. E. (2022). Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials. Diabetes, Obesity and Metabolism, 24(5), 868-880.
18. Nguyen, N. P. T., Cong, T. L., Tran, T. T. H., Do, B. N., Nguyen, S. T., Vu, B. T., ... & Le, T. D. (2022). Lower Plasma Albumin, Higher White Blood Cell Count and High-Sensitivity C-Reactive Protein are Associated with Femoral Artery Intima-Media Thickness Among Newly Diagnosed Patients with Type 2 Diabetes Mellitus. International Journal of General Medicine, 15, 2715.
19. Zhao, P., Yan, J., Pan, B., Liu, J., Fu, S., Cheng, J., ... & Li, Q. (2022). Association Between the Risk of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes and Chronic Kidney Disease. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 15, 1141.
20. Chan, T. T., Tse, Y. K., Lui, R. N. S., Wong, G. L. H., Chim, A. M. L., Kong, A. P. S., ... & Tang, R. S. Y. (2022). Fatty pancreas is independently associated with subsequent diabetes mellitus development: a 10-year prospective cohort study. Clinical Gastroenterology and Hepatology, 20(9), 2014-2022.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.